BioCentury
ARTICLE | Company News

Centocor, Pharmacia & Upjohn sales and marketing update

March 8, 1999 8:00 AM UTC

CNTO will co-promote P&U's Fragmin dalteparin low molecular weight heparin in the U.S. to treat unstable angina. An sNDA for Fragmin for this indication is under review by the FDA. P&U markets the pr...